Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

Maureen P.M.H. Rutten-van Mölken; Elisabeth Sophia Hartgers-Gubbels; Michael Chambers

doi:10.2147/IJGM.S391712

Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

Maureen P.M.H. Rutten-van Mölken, Elisabeth Sophia Hartgers-Gubbels^*, Michael Chambers

^*Corresponding author for this work

Health Technology Assessment (HTA)

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Downloads (Pure)

Abstract

How is a cost-effectiveness analysis constructed and used? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Maureen Rutten-van Molken about economic evaluations in healthcare and how value is considered in these evaluations. Prof. Rutten-van Molken is professor of Economic Evaluation of Innovations for Health at the Erasmus University Rotterdam in the Netherlands. She leads the Erasmus HTA department and is Scientific Director of the Institute for Medical Technology Assessment (iMTA). Prof Rutten-van Molken explains how comparative assessments can help us understand which treatments offer the best value-for-money as reimbursement can only be allocated to a selection of all possible treatments.

Original language	English
Pages (from-to)	8055-8061
Number of pages	7
Journal	International Journal of General Medicine
Volume	15
DOIs	https://doi.org/10.2147/IJGM.S391712
Publication status	Published - 9 Nov 2022

Bibliographical note

Access to Document

10.2147/IJGM.S391712Licence: CC BY-NC

IJGM-391712-value-insider-season-1-episode-4--how-are-costs-measured--anFinal published version, 462 KBLicence: CC BY-NC

Cite this

@article{235dff244bdf409ca752a93134e8a89a,

title = "Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]",

abstract = "How is a cost-effectiveness analysis constructed and used? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Maureen Rutten-van Molken about economic evaluations in healthcare and how value is considered in these evaluations. Prof. Rutten-van Molken is professor of Economic Evaluation of Innovations for Health at the Erasmus University Rotterdam in the Netherlands. She leads the Erasmus HTA department and is Scientific Director of the Institute for Medical Technology Assessment (iMTA). Prof Rutten-van Molken explains how comparative assessments can help us understand which treatments offer the best value-for-money as reimbursement can only be allocated to a selection of all possible treatments.",

author = "{Rutten-van M{\"o}lken}, {Maureen P.M.H.} and Hartgers-Gubbels, {Elisabeth Sophia} and Michael Chambers",

note = "{\textcopyright} 2022 Boehringer Ingelheim International GmbH.",

year = "2022",

month = nov,

day = "9",

doi = "10.2147/IJGM.S391712",

language = "English",

volume = "15",

pages = "8055--8061",

journal = "International Journal of General Medicine",

issn = "1178-7074",

publisher = "Dove Medical Press Ltd.",

}

Value Insider Season 1 Episode 4 : How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]. / Rutten-van Mölken, Maureen P.M.H.; Hartgers-Gubbels, Elisabeth Sophia; Chambers, Michael.

In: International Journal of General Medicine, Vol. 15, 09.11.2022, p. 8055-8061.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Value Insider Season 1 Episode 4

T2 - How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

AU - Rutten-van Mölken, Maureen P.M.H.

AU - Hartgers-Gubbels, Elisabeth Sophia

AU - Chambers, Michael

PY - 2022/11/9

Y1 - 2022/11/9

N2 - How is a cost-effectiveness analysis constructed and used? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Maureen Rutten-van Molken about economic evaluations in healthcare and how value is considered in these evaluations. Prof. Rutten-van Molken is professor of Economic Evaluation of Innovations for Health at the Erasmus University Rotterdam in the Netherlands. She leads the Erasmus HTA department and is Scientific Director of the Institute for Medical Technology Assessment (iMTA). Prof Rutten-van Molken explains how comparative assessments can help us understand which treatments offer the best value-for-money as reimbursement can only be allocated to a selection of all possible treatments.

AB - How is a cost-effectiveness analysis constructed and used? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Maureen Rutten-van Molken about economic evaluations in healthcare and how value is considered in these evaluations. Prof. Rutten-van Molken is professor of Economic Evaluation of Innovations for Health at the Erasmus University Rotterdam in the Netherlands. She leads the Erasmus HTA department and is Scientific Director of the Institute for Medical Technology Assessment (iMTA). Prof Rutten-van Molken explains how comparative assessments can help us understand which treatments offer the best value-for-money as reimbursement can only be allocated to a selection of all possible treatments.

UR - http://www.scopus.com/inward/record.url?scp=85141473839&partnerID=8YFLogxK

U2 - 10.2147/IJGM.S391712

DO - 10.2147/IJGM.S391712

M3 - Comment/Letter to the editor

AN - SCOPUS:85141473839

VL - 15

SP - 8055

EP - 8061

JO - International Journal of General Medicine

JF - International Journal of General Medicine

SN - 1178-7074

ER -

Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this